ANDROGENETIC ALOPECIA (AGA)
Clinical trials for ANDROGENETIC ALOPECIA (AGA) explained in plain language.
Never miss a new study
Get alerted when new ANDROGENETIC ALOPECIA (AGA) trials appear
Sign up with your email to follow new studies for ANDROGENETIC ALOPECIA (AGA), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill aims to reverse hair loss in women
Disease control Recruiting nowThis study is testing an investigational oral pill called VDPHL01 for women with genetic hair loss (female pattern baldness). It's a large, late-stage trial comparing the drug to a placebo to see if it safely increases hair count and improves appearance. The study lasts about 13 …
Matched conditions: ANDROGENETIC ALOPECIA (AGA)
Phase: PHASE3 • Sponsor: Veradermics, Inc. • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
New baldness shot enters human testing
Disease control Recruiting nowThis study is testing an experimental injection called OLX72021 for men with mild to moderate male pattern baldness. The main goals are to see if the treatment is safe and if it helps increase hair count in a specific area of the scalp. Participants will receive either the real i…
Matched conditions: ANDROGENETIC ALOPECIA (AGA)
Phase: PHASE1, PHASE2 • Sponsor: Olix Pharmaceuticals, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
Could this be the next big breakthrough for hair loss?
Disease control Recruiting nowThis early-stage clinical trial is testing a new medication called ABS-201 to see if it is safe and well-tolerated for improving hair growth. The study will involve healthy adults and people with common genetic hair loss (pattern baldness). Participants will receive either the ac…
Matched conditions: ANDROGENETIC ALOPECIA (AGA)
Phase: PHASE1, PHASE2 • Sponsor: Absci Pty Ltd. • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC